phenylalanine has been researched along with Hyperglycemia, Postprandial in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.14) | 18.7374 |
| 1990's | 2 (4.76) | 18.2507 |
| 2000's | 27 (64.29) | 29.6817 |
| 2010's | 9 (21.43) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Burd, NA; Churchward-Venne, TA; de Groot, LCPGM; Dirks, ML; Fuchs, CJ; Gorissen, SHM; Groen, BBL; Holwerda, AM; Horstman, AMH; Koopman, R; Kouw, IWK; Pennings, B; Res, PT; Senden, JMG; Steijns, JMJM; Trommelen, J; van Loon, LJC; Verdijk, LB; Wall, BT | 1 |
| Adachi, T; Fukase, K; Ito, J; Katagiri, T; Kitagawa, M; Ohta, I; Yamanaka, Y | 1 |
| Kim, SS; Koide, M; Nagasawa, Y; Sawada, T; Shiotani, H; Terashita, D; Yokoyama, M | 1 |
| Chino, Y; Goto, D; Hayashi, T; Ito, S; Kondo, Y; Matsumoto, I; Ogishima, H; Sugihara, M; Sumida, T | 1 |
| Breitschaft, A; Darstein, C; Golor, G; Hermosillo Reséndiz, K; Hu, K | 1 |
| Nakashima, E | 1 |
| Christiansen, B; Dominguez, H; Hermann, TS; Ihlemann, N; Kveiborg, B; Køber, L; Major-Pedersen, A; Nielsen, D; Rask-Madsen, C; Svendsen, OL; Torp-Pedersen, C | 1 |
| Asano, T; Doi, Y; Iida, M; Iino, K; Iwase, M | 1 |
| Buse, JB; Einhorn, D | 1 |
| Bellomo Damato, A; Giorgino, F; Giorgino, R; Laviola, L; Stefanelli, G | 1 |
| Grunberger, G | 1 |
| Allister, EM; Bhattacharjee, A; Wheeler, MB | 1 |
| Mayes, K; Morgan, C; Tan, M | 1 |
| Foley, JE; Gatlin, MR; Rosenstock, J; Shen, SG | 1 |
| Ball, M; Dickinson, S; Hershon, K; Holmes, D; Saloranta, C | 1 |
| Davies, MJ | 1 |
| Chinkes, DL; Gore, DC; Hart, DW; Herndon, DN; Sanford, AP; Wolf, SE | 1 |
| Caminos, QR; Chacín, LF; de la Torre, W; Islas-Andrade, S; López, G; Martínez de Hurtado, E; Revilla-Monsalve, MC; Yupanqui, H | 1 |
| Yamada, K | 1 |
| Odawara, M | 1 |
| Carroll, MF; Castro, M; Gutierrez, A; Schade, DS; Tsewang, D | 1 |
| Ferriman, A | 1 |
| Kitahara, Y; Mine, T; Miura, K; Mori, Y; Tajima, N | 1 |
| Kuriyama, G; Mori, Y; Tajima, N | 1 |
| Ohyama, Y; Tomono, S; Uchiyama, T | 1 |
| Hirose, T | 2 |
| Byun, J; Danda, R; Heinecke, JW; Heller, JI; Ido, Y; Pennathur, S; Pergola, P; Williamson, JR | 1 |
| Gorogawa, S; Hazama, Y; Hori, M; Kaneto, H; Kato, K; Kawamori, D; Matsuhisa, M; Nakamura, Y; Ohtoshi, K; Shiraiwa, T; Yamasaki, Y; Yoshiuchi, K | 1 |
| Chen, JY; Li, G; Lü, GL; Xu, QW | 1 |
| Arakawa, M; Hirose, T | 1 |
| Ashokkumar, N; Pari, L; Rao, ChA | 1 |
| Kapoor, JR | 1 |
| Barazzoni, R; Biolo, G; Dal Mas, V; De Cicco, M; Fantin, D; Guarnieri, G; Iapichino, G; Lorenzon, S; Paroni, R; Zanetti, M | 1 |
| Abumrad, NN; Flakoll, PJ; Hill, JO; May, MM; Rice, DE | 1 |
| Dusting, GJ; Ritchie, RH; Rosenkranz, AC | 1 |
| Kawamori, R; Nishiyama, K; Niwa, M; Shimizu, T; Uchino, H | 1 |
| Hanif, W; Kumar, S | 1 |
| Pratt, OE | 1 |
| Parekh, NB; Sanders, RB | 1 |
| Asakuma, K; Fujimoto, S; Hayashi, T; Tomoda, T | 1 |
11 review(s) available for phenylalanine and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Protein Type, Protein Dose, and Age Modulate Dietary Protein Digestion and Phenylalanine Absorption Kinetics and Plasma Phenylalanine Availability in Humans.
Topics: Adult; Aged; Aging; Biological Transport; Dietary Proteins; Digestion; Female; Humans; Hyperglycemia; Male; Middle Aged; Phenylalanine | 2020 |
Quo vadis nateglinide? Ten-year perspective.
Topics: Animals; Blood Glucose; Clinical Trials, Phase II as Topic; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Nateglinide; Phenylalanine; Randomized Controlled Trials as Topic | 2011 |
Insulin secretagogues.
Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Nateglinide; Phenylalanine; Piperidines; Postprandial Period; Sulfonylurea Compounds; United Kingdom | 2002 |
[Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
Topics: Acarbose; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Inositol; Insulin Resistance; Nateglinide; Obesity; Phenylalanine; Postprandial Period | 2003 |
[Nateglinide and mitiglinide].
Topics: Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Resistance; Insulin Secretion; Isoindoles; Metformin; Nateglinide; Phenylalanine; Postprandial Period; Stimulation, Chemical | 2003 |
[Pathophysiological conditions progressing from impaired glucose tolerance: coronary artery disease (ischemic heart disease)].
Topics: Acarbose; Cyclohexanes; Fasting; Glucose Intolerance; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Life Style; Myocardial Ischemia; Nateglinide; Phenylalanine; Pioglitazone; Postprandial Period; Protein Kinase C; Thiazolidinediones | 2005 |
[Effects of nateglinide in impaired glucose tolerance subjects].
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Cyclohexanes; Diabetes Mellitus, Type 2; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Nateglinide; Obesity; Phenylalanine; Postprandial Period; Risk Factors | 2005 |
[Significance of insulin secretion pattern lectured by "glinides" in the treatment of postprandial hyperglycemia].
Topics: Cyclohexanes; Diabetes Mellitus, Type 2; Eating; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine | 2005 |
[Glinide(s), sulfonylurea(s)].
Topics: Arteriosclerosis; Cardiovascular Diseases; Cyclohexanes; Diabetic Angiopathies; Glucose Intolerance; Hyperglycemia; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine; Postprandial Period; Risk Factors; Sulfonylurea Compounds | 2006 |
Nateglinide: a new rapid-acting insulinotropic agent.
Topics: Animals; Clinical Trials as Topic; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Guidelines as Topic; Humans; Hyperglycemia; Hypoglycemic Agents; Metformin; Microcirculation; Molecular Structure; Nateglinide; Phenylalanine; Postprandial Period | 2001 |
The transport of metabolizable substances into the living brain.
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Animals; Biological Transport, Active; Blood Glucose; Blood-Brain Barrier; Brain; Glucose; Haplorhini; Humans; Hyperglycemia; Insulin; Ketone Bodies; Lactates; Neurotransmitter Agents; Papio; Phenylalanine; Pyruvates; Rats; Renal Aminoacidurias; Thyroid Hormones; Tryptophan | 1976 |
14 trial(s) available for phenylalanine and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.
Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; Coronary Artery Disease; Cyclohexanes; Diabetic Angiopathies; Dyslipidemias; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Nateglinide; Phenylalanine | 2014 |
Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study.
Topics: Adamantane; Adolescent; Adult; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Healthy Volunteers; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liraglutide; Male; Maximum Tolerated Dose; Metformin; Middle Aged; Nateglinide; Nitriles; Phenylalanine; Prognosis; Pyrrolidines; Somatostatin; Vildagliptin; Young Adult | 2014 |
Effects of acute and chronic attenuation of postprandial hyperglycemia on postglucose-load endothelial function in insulin resistant individuals: is stimulation of first phase insulin secretion beneficial for the endothelial function?
Topics: Blood Glucose; Case-Control Studies; Cyclohexanes; Endothelium; Female; Glucose; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period; Risk Factors; Vasodilation | 2008 |
Nateglinide may increase high-molecular weight adiponectin in type 2 diabetic patients with hypoadiponectinemia.
Topics: Adiponectin; Aged; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Molecular Weight; Nateglinide; Phenylalanine | 2008 |
Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Fasting; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2011 |
Effect of hyperalimentation and insulin-treated hyperglycemia on tyrosine levels in very preterm infants receiving parenteral nutrition.
Topics: Birth Weight; Blood Glucose; Humans; Hyperglycemia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Insulin; Parenteral Nutrition Solutions; Parenteral Nutrition, Total; Phenylalanine; Tyrosine | 2014 |
Combination therapy with nateglinide and a thiazolidinedione improves glycemic control in type 2 diabetes.
Topics: Adult; Aged; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Thiazoles; Thiazolidinediones; Treatment Outcome | 2002 |
Efficacy and safety of nateglinide in type 2 diabetic patients with modest fasting hyperglycemia.
Topics: Adult; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incidence; Insulin; Insulin Secretion; Male; Nateglinide; Phenylalanine; Racial Groups; Treatment Outcome | 2002 |
Evaluation of the effects of nateglinide on postprandial glycemia in patients with type 2 diabetes mellitus: a multicenter, multinational, non-randomized, non-controlled Latin American study.
Topics: Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Latin America; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period; Treatment Outcome | 2003 |
Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Female; Glipizide; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2003 |
Effects of nateglinide on the elevation of postprandial remnant-like particle triglyceride levels in Japanese patients with type 2 diabetes assessment by meal tolerance test.
Topics: Blood Glucose; Cholesterol; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Japan; Lipoproteins; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period; Triglycerides | 2004 |
Beneficial effects of nateglinide on insulin resistance in type 2 diabetes.
Topics: Blood Glucose; Body Mass Index; Cyclohexanes; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2006 |
Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery.
Topics: Abdominal Neoplasms; Amino Acids; Arginine; Blood Glucose; Cancer Care Facilities; Combined Modality Therapy; Critical Care; Cross-Over Studies; Energy Metabolism; Female; Glutamine; Humans; Hyperglycemia; Insulin; Insulin Resistance; Leucine; Middle Aged; Muscle Proteins; Muscle, Skeletal; Overweight; Parenteral Nutrition, Total; Phenylalanine; Postoperative Complications; Radiotherapy, Adjuvant | 2008 |
Impairment of early insulin response after glucose load, rather than insulin resistance, is responsible for postprandial hyperglycemia seen in obese type 2 diabetes: assessment using nateglinide, a new insulin secretagogue.
Topics: Adult; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Nateglinide; Obesity; Phenylalanine; Postprandial Period | 2000 |
17 other study(ies) available for phenylalanine and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Diabetic Hemichorea-hemiballism after Prompt Improvement in Hyperglycemia.
Topics: Chorea; Cyclohexanes; Diabetes Complications; Dyskinesias; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Linagliptin; Lower Extremity; Magnetic Resonance Imaging; Male; Middle Aged; Nateglinide; Phenylalanine | 2017 |
Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases.
Topics: Acarbose; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Glucose; Connective Tissue Diseases; Cyclohexanes; Diabetes Mellitus; Early Diagnosis; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Prednisolone; Treatment Outcome | 2014 |
[Prandial glucose regulator and insulin secretagogue; glinide and its combination therapy].
Topics: Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperglycemia; Hypoglycemic Agents; Isoindoles; Nateglinide; Phenylalanine | 2015 |
Panel discussion on achieving glycemic control.
Topics: Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Metformin; Nateglinide; Phenylalanine; Sulfonylurea Compounds | 2001 |
MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucose; Glucose Intolerance; Homeostasis; Hyperglycemia; Hyperinsulinism; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Obese; Phenylalanine; Triazoles | 2012 |
[Dangerous postprandial glucose peaks. Risk for heart and blood vessels].
Topics: Cyclohexanes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Metformin; Nateglinide; Phenylalanine; Postprandial Period | 2002 |
Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients.
Topics: Adult; Aged; Burns; Calorimetry, Indirect; Energy Metabolism; Humans; Hyperglycemia; Insulin Resistance; Middle Aged; Muscle Proteins; Phenylalanine; Retrospective Studies | 2002 |
Novartis breached code after doctors say it "invented" a disease.
Topics: Advertising; Blood Glucose; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Disclosure; Drug Industry; Europe; Family Practice; Humans; Hyperglycemia; Hypoglycemic Agents; Meta-Analysis as Topic; Nateglinide; Phenylalanine; Prospective Studies; Risk; United Kingdom | 2002 |
Role of early insulin secretion in postglucose-loading hyperglycaemia and postfat-loading hyperlipidaemia: comparing nateglinide and glibenclamide for acute effects on insulin secretion in OLETF rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Dietary Fats; Gene Expression Regulation; Glyburide; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Secretion; Lipoprotein Lipase; Male; Nateglinide; Phenylalanine; Postprandial Period; Rats; Rats, Inbred OLETF; Rats, Long-Evans; RNA, Messenger; Triglycerides | 2004 |
Reactive carbonyls and polyunsaturated fatty acids produce a hydroxyl radical-like species: a potential pathway for oxidative damage of retinal proteins in diabetes.
Topics: Amino Acids; Animals; Antioxidants; Carbon; Cerebral Cortex; Chromatography, High Pressure Liquid; Diabetes Mellitus; Diabetes Mellitus, Experimental; Fatty Acids, Unsaturated; Glucose; Guanidines; Hydroxyl Radical; Hyperglycemia; Lipid Metabolism; Lipid Peroxidation; Lipoproteins, LDL; Male; Mass Spectrometry; Oxidative Stress; Oxygen; Phenylalanine; Rats; Rats, Sprague-Dawley; Retina; Ribonuclease, Pancreatic; Temperature; Tyrosine | 2005 |
Determination of the nateglinide polymorphism structure and the drug effect.
Topics: Animals; Blood Glucose; Crystallization; Cyclohexanes; Female; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred ICR; Nateglinide; Phenylalanine; X-Ray Diffraction | 2005 |
Effect of N-benzoyl-D-phenylalanine and metformin on insulin receptors in neonatal streptozotocin-induced diabetic rats: studies on insulin binding to erythrocytes.
Topics: Animals; Animals, Newborn; Binding, Competitive; Blood Glucose; Diabetes Mellitus, Experimental; Erythrocyte Membrane; Female; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Phenylalanine; Pregnancy; Protein Binding; Rats; Rats, Wistar; Receptor, Insulin; Streptozocin | 2006 |
Postprandial hyperglycemia: are all sulfonylureas created equal?
Topics: Carbamates; Cyclohexanes; Glipizide; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Nateglinide; Phenylalanine; Piperidines; Postprandial Period; Sulfonylurea Compounds | 2008 |
The opposing effects of insulin and hyperglycemia in modulating amino acid metabolism during a glucose tolerance test in lean and obese subjects.
Topics: Adult; Amino Acids; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Isoleucine; Leucine; Male; Obesity; Phenylalanine; Reference Values | 1994 |
Hyperglycaemia abolishes the antihypertrophic efficacy of bradykinin in rat ventricular myocytes.
Topics: Angiotensin II; Animals; Aorta; Bradykinin; Cardiomegaly; Cattle; Coculture Techniques; Endothelium, Vascular; Glucose; Heart Ventricles; Hyperglycemia; Male; Myocardium; Phenylalanine; Rats; Rats, Sprague-Dawley | 1999 |
L-tryptophan antagonism of epinephrine-induced hyperglycemia in rats.
Topics: Animals; Blood Glucose; Epinephrine; Female; Histidine; Hyperglycemia; Phenylalanine; Rats; Time Factors; Tryptophan; Tyrosine | 1970 |
Studies on DOPA- and dopamine-hyperglycemia.
Topics: Amines; Amino Acids; Animals; Blood Glucose; Dihydroxyphenylalanine; Dopamine; Epinephrine; Hyperglycemia; Phenylalanine; Rabbits; Tyrosine | 1968 |